Association of TP53 Intron 3, 16 bp Duplication Polymorphism With Esophageal and Gastric Cancer Susceptibility in Kashmir Valley

Author(s):  
Manzoor Ahmad Malik ◽  
Kokil Sharma ◽  
Shivangi Goel ◽  
Showkat Ali Zargar ◽  
Balraj Mittal
2009 ◽  
Vol 40 (1-2) ◽  
pp. 26-32 ◽  
Author(s):  
Manzoor A. Malik ◽  
Rohit Upadhyay ◽  
Rama D. Mittal ◽  
Showket A. Zargar ◽  
Dinesh R. Modi ◽  
...  

2005 ◽  
Vol 26 (12) ◽  
pp. 2046-2049 ◽  
Author(s):  
M. Brito ◽  
J. Malta-Vacas ◽  
B. Carmona ◽  
C. Aires ◽  
P. Costa ◽  
...  

2017 ◽  
Vol 216-217 ◽  
pp. 111-119 ◽  
Author(s):  
Thomas Slavin ◽  
Susan L. Neuhausen ◽  
Christina Rybak ◽  
Ilana Solomon ◽  
Bita Nehoray ◽  
...  

2018 ◽  
Vol 38 (6) ◽  
Author(s):  
Hongpeng Zhao ◽  
Lixia Liu ◽  
Bo Liu ◽  
Yanmin Wang ◽  
Feng Li ◽  
...  

Polymorphisms in the tumor necrosis factor α (TNF-α) gene are emerging as key determinants of gastric diseases. The TNF-α-238G/A single-nucleotide polymorphism (SNP) is the most extensively studied. However, this association is inconsistent amongst different populations. We therefore conducted an updated meta-analysis to obtain a more precise estimate of the association of TNF-α-238G/A polymorphism with gastric cancer (GC) risk. A comprehensive search of PubMed, Embase, Chinese (CNKI and WanFang) databases was performed to identify relevant studies through 5 May 2018. Odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of the association. Fourteen studies were included in our meta-analysis involving 2999 cases and 4685 controls. There was no significant association between TNF-α-238G/A polymorphism and GC risk in the overall populations. In the subgroup analysis, we found that TNF-α-238G/A polymorphism was associated with the increased risk of GC amongst Asians, especially in Chinese, but not in Caucasians. Subgroup analysis by genotyping methods revealed increased risk for other methods. In conclusion, our present meta-analysis shows that TNF-α-238G/A polymorphism is associated with the risk of GC in East Asian individuals.


2015 ◽  
Vol 148 (4) ◽  
pp. S-63 ◽  
Author(s):  
Maria Asuncion García-González ◽  
Luis Bujanda ◽  
Enrique Quintero ◽  
Santos Santolaria ◽  
Rafael Benito ◽  
...  

2018 ◽  
Vol 22 (3) ◽  
pp. 640-644 ◽  
Author(s):  
Seon Woo Lee ◽  
Do Youn Park ◽  
Mi-Young Kim ◽  
Changwon Kang

2015 ◽  
Vol 22 (2) ◽  
pp. 317-322 ◽  
Author(s):  
Florin Burada ◽  
Marius Eugen Ciurea ◽  
Raluca Nicoli ◽  
Ioana Streata ◽  
Ionica Dan Vilcea ◽  
...  

2020 ◽  
Vol 21 (14) ◽  
pp. 4904
Author(s):  
Laura Caggiari ◽  
Mara Fornasarig ◽  
Mariangela De Zorzi ◽  
Renato Cannizzaro ◽  
Agostino Steffan ◽  
...  

Hereditary diffuse gastric cancer (HDGC) is a cancer susceptibility syndrome caused by germline pathogenic variant in CDH1, the gene encoding E-cadherin. The germline loss-of-function variants are the only proven cause of the cancer syndrome HDGC, occurring in approximately 10–18% of cases and representing a helpful tool in genetic counseling. The current case reports the family history based on a CDH1 gene variant, c.360delG, p.His121Thr in a suspected family for hereditary gastric cancer form. This frameshift deletion generates a premature stop codon at the amino acid 214, which leads to a truncated E-cadherin protein detecting it as a deleterious variant. The present study expands the mutational spectra of the family with the CDH1 variant. Our results highlight the clinical impact of the reported CDH1 variant running in gastric cancer families.


Sign in / Sign up

Export Citation Format

Share Document